Search results
New treatment could reverse hair loss caused by autoimmune skin disease alopecia areata
Medical Xpress· 22 hours agoThe team has developed a microneedle patch that can be painlessly applied to the scalp and releases...
Takeda tackles $900m restructuring plan after generics hurt annual profits
Pharmaceutical Technology via Yahoo Finance· 21 hours agoTakeda shared progress in an earnings call from six late-stage programmes that it says have the...
Celltrion USA's adalimumab-aaty biosimilar to HUMIRA® now available at low wholesale acquisition...
FOX 23 News Albany· 12 hours agoCelltrion USA announced today that adalimumab-aaty, the company's high-concentration (100 mg/mL) and citrate-free formulation biosimilar to HUMIRA ® (adalimumab), is now available at a low wholesale ...
Vanda Pharmaceuticals Inc. (NASDAQ:VNDA) Q1 2024 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 19 hours agoVanda Pharmaceuticals Inc. (NASDAQ:VNDA) Q1 2024 Earnings Call Transcript May 8, 2024 Vanda...
20 Craziest Met Gala Outfits: From Katy Perry's Chandelier-Inspired Costume to Zendaya's Cinderella...
OK! Magazine· 4 days agoAlton Mason turned heads at the 2023 Met Gala in his custom Karl Lagerfeld couture, designed by...
15 Weird Symptoms You Should NEVER Ignore
Cheapism via AOL· 4 days agoEasily ignored symptoms like itchy skin, blurred vision, and swollen ankles can indicate big health problems in your future. Find out what to watch out...
Kim Kardashian Looks Unreal and That’s the Problem
Teen Vogue· 3 days agoIn this op-ed, Teen Vogue Features Director Brittney McNamara reminds us why we shouldn’t look to Kim Kardashian or other celebrities to set the bar on...
Protagonist Reports First Quarter 2024 Financial Results and Provides Corporate Update
Morningstar· 3 days agoEntered into a worldwide license and collaboration agreement for rusfertide with Takeda; Cash runway extended through Q4 2027[1]Enrollment in both Phase 3 ICONIC LEAD and ICONIC TOTAL trials ...
Japan's Takeda Pharma to restructure after annual profit slump
Reuters via Yahoo News· 1 day agoTOKYO (Reuters) -Japan's Takeda Pharmaceutical announced a restructuring on Thursday after annual...
Q1 2024 Vanda Pharmaceuticals Inc Earnings Call
Thomson Reuters StreetEvents via Yahoo Finance· 1 day agoIn addition, Vanda is evaluating PONVORY in additional autoimmune disorders, including psoriasis and ulcerative colitis. Prior to our acquisition, PONVORY was tested in patients ...